Compare DIOD & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | LGND |
|---|---|---|
| Founded | 1959 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 1995 | N/A |
| Metric | DIOD | LGND |
|---|---|---|
| Price | $87.11 | $300.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $92.67 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 490.2K | 354.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.53 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.08 | $1.25 |
| Revenue Next Year | $14.46 | $19.41 |
| P/E Ratio | $289.81 | ★ $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.28 | $131.67 |
| 52 Week High | $125.99 | $326.63 |
| Indicator | DIOD | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 54.03 |
| Support Level | $82.00 | $290.20 |
| Resistance Level | $99.29 | $326.63 |
| Average True Range (ATR) | 4.85 | 10.96 |
| MACD | -0.33 | -3.74 |
| Stochastic Oscillator | 29.90 | 24.94 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.